With regard to flu vaccines, one of the challenges that our early vaccination campaign has provided is that we are seeing many, many fewer people presenting with flu-like symptoms at the moment. Of course, that has an impact on our desire to see a good rate of community surveillance testing, because fewer people are presenting with those symptoms in the first place, whereas if we had the typical seasonal rates of infection, there'd be more people being tested for COVID-19. So it creates some interesting challenges. I still think our testing rates are too low, and the member and I have had this conversation before. We're leaning very heavily on Health to make sure we get those numbers up to a level where we can be confident.